Detalhe da pesquisa
1.
Variant-specific IgA protects against Omicron infection.
J Infect Dis
; 2023 Nov 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-37996071
2.
Prolonged inflammation in patients hospitalized for coronavirus disease 2019 (COVID-19) resolves 2 years after infection.
J Med Virol
; 95(5): e28774, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37212320
3.
Efficient recall of SARS-CoV-2 variant-reactive B cells and T responses in the elderly upon heterologous mRNA vaccines as boosters.
J Med Virol
; 95(1): e28258, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36305052
4.
Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial.
Clin Infect Dis
; 75(12): 2088-2096, 2022 12 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-35543372
5.
Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
J Clin Immunol
; 42(2): 214-229, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34716845
6.
Viral Dynamics and Immune Correlates of Coronavirus Disease 2019 (COVID-19) Severity.
Clin Infect Dis
; 73(9): e2932-e2942, 2021 11 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32856707
7.
Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.
Lancet
; 396(10251): 603-611, 2020 08 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822564
8.
Mosquito Saliva Reshapes Alphavirus Infection and Immunopathogenesis.
J Virol
; 92(12)2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29593049
9.
A Sensitive Method for Detecting Zika Virus Antigen in Patients' Whole-Blood Specimens as an Alternative Diagnostic Approach.
J Infect Dis
; 216(2): 182-190, 2017 07 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28586426
10.
Correction to: Robust Virus-Specific Adaptive Immunity in COVID-19 Patients with SARS-CoV-2 Δ382 Variant Infection.
J Clin Immunol
; 42(2): 230-231, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34837161
11.
Crosstalk between CD64+MHCII+ macrophages and CD4+ T cells drives joint pathology during chikungunya.
EMBO Mol Med
; 16(3): 641-663, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38332201
12.
Relative deficiency in interferon-γ-secreting CD4+ T cells is strongly associated with poorer COVID-19 vaccination responses in older adults.
Aging Cell
; 23(4): e14099, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38317404
13.
Longitudinal single cell atlas identifies complex temporal relationship between type I interferon response and COVID-19 severity.
Nat Commun
; 15(1): 567, 2024 Jan 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38238298
14.
Myeloperoxidase inhibition may protect against endothelial glycocalyx shedding induced by COVID-19 plasma.
Commun Med (Lond)
; 3(1): 62, 2023 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-37147421
15.
Third dose of BNT162b2 improves immune response in liver transplant recipients to ancestral strain but not Omicron BA.1 and XBB.
Front Immunol
; 14: 1206016, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37465685
16.
Higher Delta variant-specific neutralizing antibodies prevented infection in close contacts vaccinated with ancestral mRNA vaccines during the SARS-CoV-2 Delta wave.
Sci Rep
; 13(1): 19331, 2023 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37935965
17.
Rapid microfluidic platform for screening and enrichment of cells secreting virus neutralizing antibodies.
Lab Chip
; 22(13): 2578-2589, 2022 06 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-35694804
18.
Malaria abrogates O'nyong-nyong virus pathologies by restricting virus infection in nonimmune cells.
Life Sci Alliance
; 5(4)2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35039441
19.
Conserved longitudinal alterations of anti-S-protein IgG subclasses in disease progression in initial ancestral Wuhan and vaccine breakthrough Delta infections.
Front Microbiol
; 13: 1043049, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36483199
20.
Waning of specific antibodies against Delta and Omicron variants five months after a third dose of BNT162b2 SARS-CoV-2 vaccine in elderly individuals.
Front Immunol
; 13: 1031852, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36451833